| 1Nicotinamide |
|---|
| 2Nicotinic acid |
Compound Name Nicotinamide |
CID 936 |
Molecular Formula C6H6N2O |
Molecular Weight 122 |
No. Hydrogen Bond Acceptors 2 |
No. Hydrogen Bond Donors 1 |
Applications
Nicotinic acid / Nicotinamide (10 ng/mL) in Human Plasma by Impact on Gemini 3µm C18 100x4.6mm
20906
Separation Mode: Reversed Phase
Reversed Phase
C18
HPLC
Antilipemic Agents
Clinical
Clinical Research
Therapeutic / Clinical
Applications
Nicotinic acid / Nicotinamide (10 ng/mL) in Human Plasma by Impact on Gemini 3µm C18 100x4.6mm
Analytes
Details
LC Conditions (App ID: 20906)
Column: | ||||||||||||||||||||
Brand Name: | ||||||||||||||||||||
Part No: | ||||||||||||||||||||
Phase Name: C18 | ||||||||||||||||||||
Elution Type: Gradient | ||||||||||||||||||||
Mobile Phase: A: 0.1% formic acid B: Methanol 100% | ||||||||||||||||||||
Gradient Profile:
| ||||||||||||||||||||
Flow Rate: 0.6 mL/min | ||||||||||||||||||||
Temperature: 22°C | ||||||||||||||||||||
Detection: Electrospray Mass Spec (ESMS) (22°C) | ||||||||||||||||||||
Detector Info: SCIEX API 4000™ |
Sample Preparation Details
Description: Impact Protein Precipitation, 2mL Square Well Filter Plate, 2/Pk |
Part Number: |
Evaporation: Evaporate to dryness |
Order Items Used in This Application
00D-4439-E0
Gemini 3 µm C18 110 Å, LC Column 100 x 4.6 mm, Ea
Qty:
Similar Applications
search
Nicotinamide
Synergi 4 µm Polar-RP 80 Å, LC Column 150 x 4.6 mm, Ea
Reversed Phase
Luna 5 µm C18(2) 100 Å, LC Column 150 x 2 mm, Ea
Reversed Phase
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
CONNECT WITH US
